Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1

被引:65
作者
Hiratani, K
Haruta, T [1 ]
Tani, A
Kawahara, J
Usui, I
Kobayashi, M
机构
[1] Toyama Med & Pharmaceut Univ, Dept Med 1, Toyama, Japan
[2] Seiwa Hosp, Div Cardiol, Osaka, Japan
关键词
insulin signaling; insulin resistance; rapamycin; mTOR; JNK;
D O I
10.1016/j.bbrc.2005.07.152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In 3T3-L1 adipocytes, insulin or anisomycin stimulated phosphorylation of IRS-1 at Ser(307) and Ser(636/639), both of which were partially reduced by the mTOR inhibitor, rapamycin, or the JNK inhibitor, SP600125, and were further inhibited by a combination of them. Interestingly, anisomycin-induced p70(S6K) phosphorylation was reduced by SP600125, while insulin-induced p70(S6K) phosphorylation was not. Furthermore, unlike insulin, anisomycin failed to elicit translocation or degradation of IRS-1. These results indicate that mTOR and JNK play roles in phosphorylating IRS-1 serine residues, and that insulin and anisomycin are different in terms of the relationship of activation between mTOR and JNK, and the effects on IRS-1 localization and stability. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:836 / 842
页数:7
相关论文
共 19 条
[1]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[2]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[3]   CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO [J].
BROWN, EJ ;
BEAL, PA ;
KEITH, CT ;
CHEN, J ;
SHIN, TB ;
SCHREIBER, SL .
NATURE, 1995, 377 (6548) :441-446
[4]   Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation [J].
Carlson, CJ ;
White, MF ;
Rondinone, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (02) :533-539
[5]   Mechanism of action of the immunosuppressant rapamycin [J].
Dumont, FJ ;
Su, QX .
LIFE SCIENCES, 1995, 58 (05) :373-395
[6]   Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation [J].
Greene, MW ;
Sakaue, H ;
Wang, LH ;
Alessi, DR ;
Roth, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) :8199-8211
[7]   Restraining PI3K: mTOR signalling goes back to the membrane [J].
Harrington, LS ;
Findlay, GM ;
Lamb, RF .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (01) :35-42
[8]   The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins [J].
Harrington, LS ;
Findlay, GM ;
Gray, A ;
Tolkacheva, T ;
Wigfield, S ;
Rebholz, H ;
Barnett, J ;
Leslie, NR ;
Cheng, S ;
Shepherd, PR ;
Gout, I ;
Downes, CP ;
Lamb, RE .
JOURNAL OF CELL BIOLOGY, 2004, 166 (02) :213-223
[9]   A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 [J].
Haruta, T ;
Uno, T ;
Kawahara, J ;
Takano, A ;
Egawa, K ;
Sharma, PM ;
Olefsky, JM ;
Kobayashi, M .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (06) :783-794
[10]  
HARUTA T, 1995, J BIOL CHEM, V270, P27991